Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

New products, nutraceuticals added under Jan Aushadhi Pariyojana

Ruchika Sharma30 July 2023 10:00 AM IST

The product basket of Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) has 1800 medicines, 285 Surgical Equipment and Consumables.

Low-Risk Medical Device Makers Get Clarity: CDSCO Publishes Class A Risk Classification List under MDR 2017

Withdraw order on import of used medical devices: AiMed asks Govt

Ruchika Sharma29 July 2023 4:19 PM IST

AiMeD alleged that FICCI is working against the interest of domestic manufacturers.

UP STF Set to Name Pharma Firms in Multi-Crore Codeine Syrup Scam

Indian-made cold syrup sent to Iraq contains poison, test shows

Ruchika Sharma29 July 2023 2:00 PM IST

It's the fifth time in a year that testing has found an Indian exporter's drugs to contain excessive levels of ethylene glycol.

CCI approves acquisition of 59.38 percent stake in Unichem Labs by Ipca Labs

Ruchika Sharma29 July 2023 12:30 PM IST

New Delhi: The Competition Commission of India (CCI) approves the proposed combination involving acquisition of shareholding up to 59.38% of Unichem...

AstraZeneca names Sharon Barr as Executive Vice President BioPharmaceuticals RnD

Ruchika Sharma29 July 2023 11:38 AM IST

Cambridge: AstraZeneca has announced the appointment of Sharon Barr as Executive Vice President, BioPharmaceuticals R&D. Sharon will succeed Mene...

Indian Pharma industry 3rd largest in world by volume, informs Minister

Ruchika Sharma29 July 2023 10:00 AM IST

New Delhi: Indian Pharmaceuticals Industry is the 3rd largest in the world by volume and the 13th largest by value, the Minister of State in the...

Gilead Sciences gets USFDA nod for new Biktarvy indication

Gilead Sciences Trodelvy gets European Commission nod for pre-treated HR+/HER2- metastatic breast cancer

Ruchika Sharma28 July 2023 4:30 PM IST

Foster City: Gilead Sciences, Inc. has announced that the European Commission (EC) approved Trodelvy (sacituzumab govitecan) as a monotherapy for...

AstraZeneca, Jacobio Pharma ink pact for proprietary Pan-KRAS inhibitor

AstraZeneca Soliris approved in EU for children, adolescents with refractory generalised myasthenia gravis

Ruchika Sharma28 July 2023 2:30 PM IST

Soliris (eculizumab) is a first-in-class C5 complement inhibitor.

Sanofi to acquire Qunol

Ruchika Sharma28 July 2023 1:30 PM IST

Paris: Sanofi has announced it has entered into a definitive agreement to acquire ownership of Qunol, a U.S.-based brand in health & wellness....

GSK to Acquire RAPT Therapeutics for USD 2.2 Billion, Bolsters Food Allergy Drug Pipeline

GlaxoSmithKline Pharma posts 11 percent rise in Q4 profit

Ruchika Sharma28 July 2023 12:30 PM IST

Bengaluru: GlaxoSmithKline Pharmaceuticals, the Indian unit of UK's GSK plc, posted an 11% rise in first-quarter profit on Wednesday, buoyed by strong...

Lupin unveils Risperidone Long Acting Injectable in US

Lupin announces resolution of USFDA warning letter for Goa, Pithampur facilities

Ruchika Sharma28 July 2023 12:08 PM IST

Mumbai: Global pharma major Lupin Limited has announced that it has received correspondence from the US FDA that it has now addressed the concerns...

CDSCO Expert Panel Backs Akums Faropenem Dispersible Tablets, Grants CT, BE Waivers

Akums gets approval for triple combination diabetes treatment

Ruchika Sharma27 July 2023 4:50 PM IST

Delhi: Akums Drugs and Pharmaceuticals Limited has secured approval for its triple combination diabetes treatment. Sitagliptin 100, Pioglitazone 15...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok